The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 15, 2018

Filed:

Dec. 10, 2014
Applicant:

Biomet Deutschland Gmbh, Berlin, DE;

Inventor:

Nicole Duewelhenke, Berlin, DE;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4709 (2006.01); A61K 31/65 (2006.01); A61K 31/7048 (2006.01); A61K 31/7088 (2006.01); A61K 31/16 (2006.01); A61K 31/395 (2006.01); A61K 31/496 (2006.01); A61L 27/54 (2006.01); A61K 31/665 (2006.01); A61K 38/12 (2006.01); A61K 45/06 (2006.01); A61L 31/16 (2006.01); A61F 2/32 (2006.01); A61F 2/38 (2006.01); A61F 2/40 (2006.01); A61F 2/44 (2006.01); A61K 31/7036 (2006.01); A61K 38/08 (2006.01); A61L 27/06 (2006.01); A61L 27/28 (2006.01);
U.S. Cl.
CPC ...
A61L 27/54 (2013.01); A61F 2/32 (2013.01); A61F 2/38 (2013.01); A61F 2/3804 (2013.01); A61F 2/40 (2013.01); A61F 2/44 (2013.01); A61K 31/395 (2013.01); A61K 31/4709 (2013.01); A61K 31/496 (2013.01); A61K 31/65 (2013.01); A61K 31/665 (2013.01); A61K 31/7036 (2013.01); A61K 31/7048 (2013.01); A61K 31/7088 (2013.01); A61K 38/08 (2013.01); A61K 38/12 (2013.01); A61K 45/06 (2013.01); A61L 27/06 (2013.01); A61L 27/28 (2013.01); A61L 31/16 (2013.01); A61L 2300/406 (2013.01); A61L 2300/45 (2013.01); A61L 2420/06 (2013.01);
Abstract

Use of a pharmaceutical composition for the local treatment or prevention of a tissue infection at an infection site, the pharmaceutical composition comprising at least two different antibiotics of group A or pharmaceutically acceptable derivatives thereof, or an antibiotic of group A and at least one antibiotic of group B or pharmaceutically acceptable derivatives thereof. Group A comprises primarily intracellular active antibiotics working as inhibitor of bacterial RNA polymerase; as inhibitor of gyrase; or as inhibitor of bacterial protein synthesis. Group B comprises primarily extracellular active antibiotics working as inhibitor of bacterial cell wall synthesis; or inhibitor of bacterial protein synthesis; or by direct destabilization or rupture of the bacterial cell wall.


Find Patent Forward Citations

Loading…